Literature DB >> 19926068

Ten-year longitudinal visual function and Nd: YAG laser capsulotomy rates in patients less than 65 years at cataract surgery.

Britta Lundqvist1, Eva Mönestam.   

Abstract

PURPOSE: To investigate the longitudinal subjective and objective visual functional results in adult cataract patients younger than 65 years at surgery. To evaluate the 10-year cumulative incidence of neodymium-yttrium-aluminum-garnet (Nd:YAG) laser treatment.
DESIGN: A prospective, longitudinal, population-based cohort study.
METHODS: The study comprised 116 patients younger than 65 years who had cataract surgery during 1 year at Norrlands University Hospital, Umeå, Sweden. Most patients (94%) had received implantation with a hydrophobic acrylic intraocular lens. Evaluated were visual acuity (VA) and visual function questionnaire (VF-14) results before and after surgery. A comparison with patients 65 years or older at surgery was made. Ten years later, 102 survivors were offered eye examinations and again asked to fill out the questionnaire. Past Nd:YAG laser treatment, as well as high- and low-contrast VA results, were analyzed.
RESULTS: Ten years postoperatively, 37% of the patients under 65 at surgery had been treated with Nd:YAG in comparison to 20% of the older patients. The cumulative incidence for not having Nd:YAG over 10 years was 72% for those under 65 and 85% for the patients 65 years or more at surgery. Eighteen percent of the younger patients had lost more than 0.1 logarithm of the minimal angle of resolution (logMAR) units of the operated eye, compared with 37% of the older (P = .00003). A reduction in VF-14 score of 10 points or more was found in 9% of the younger and 28% of the older cataract surgery patients (P = .00004).
CONCLUSION: Ten years after surgery, subjective and objective visual function remained stable in most patients younger than 65 years at surgery. More than one-third had received a posterior capsulotomy. Only a few patients with posterior capsular opacification requiring Nd:YAG were untreated at the 10-year follow-up. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19926068     DOI: 10.1016/j.ajo.2009.08.029

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

1.  Five-year postoperative outcomes of apodized diffractive multifocal intraocular lens implantation.

Authors:  Mami Yoshino; Hiroko Bissen-Miyajima; Keiichiro Minami; Yoko Taira
Journal:  Jpn J Ophthalmol       Date:  2013-09-28       Impact factor: 2.447

2.  Growth factor restriction impedes progression of wound healing following cataract surgery: identification of VEGF as a putative therapeutic target.

Authors:  Julie A Eldred; Matthew McDonald; Helen S Wilkes; David J Spalton; I Michael Wormstone
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

Review 3.  Surface Modification of Intraocular Lenses.

Authors:  Qi Huang; George Pak-Man Cheng; Kin Chiu; Gui-Qin Wang
Journal:  Chin Med J (Engl)       Date:  2016-01-20       Impact factor: 2.628

4.  Electric field exposure promotes epithelial‑mesenchymal transition in human lens epithelial cells via integrin β1‑FAK signaling.

Authors:  Jun Liu; Xiao-Long Yan; Xiao-Liang Zheng; Lin Mei; Song Wang; Jing Han; Hong Yan
Journal:  Mol Med Rep       Date:  2017-07-26       Impact factor: 2.952

5.  A meta-analysis of Nd:YAG capsulotomy rates for two hydrophobic intraocular lens materials.

Authors:  Mark Von Tress; James S Marotta; Stephen S Lane; Ramesh Sarangapani
Journal:  Clin Ophthalmol       Date:  2018-06-22

6.  The Effect of Capsulotomy Shape on Intraocular Light-Scattering after Nd:YAG Laser Capsulotomy.

Authors:  Jun Li; Zhe Yu; Hui Song
Journal:  J Ophthalmol       Date:  2020-03-23       Impact factor: 1.909

7.  Visual Quality Assessment of Posterior Capsule Opacification Using Optical Quality Analysis System (OQAS).

Authors:  Hui Zhang; Jing Wang
Journal:  J Ophthalmol       Date:  2017-10-03       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.